anti-inflammatory + CNS agent (CombinatoRx)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameanti-inflammatory + CNS agent (CombinatoRx)
Drug Alias NameCRx-153
ClassificationSmall molecules
Mechanisms of ActionCytokines modulators
TargetsCytokines
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesZalicus Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZalicus Inc
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A